Nonpediatric Specialties Face Smaller Return Margins for HPV Vaccine Costs
MONDAY, July 31, 2023 -- For nonpediatric specialties, return margins for human papillomavirus (HPV) vaccine costs by private payers are small, according to a study published in the July/August issue of the Annals of Family Medicine.
Yenan Zhu,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cervical Cancer Vaccine | Genital Warts | Human Papillomavirus (HPV) | Pharmaceuticals | Study | Vaccines